Home Cart 0 Sign in  

[ CAS No. 109523-13-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 109523-13-9
Chemical Structure| 109523-13-9
Structure of 109523-13-9 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 109523-13-9 ]

Related Doc. of [ 109523-13-9 ]

Alternatived Products of [ 109523-13-9 ]
Product Citations

Product Details of [ 109523-13-9 ]

CAS No. :109523-13-9 MDL No. :MFCD09750486
Formula : C14H23NO4 Boiling Point : -
Linear Structure Formula :- InChI Key :POJYGQHOQQDGQZ-DCAQKATOSA-N
M.W : 269.34 Pubchem ID :2755991
Synonyms :
Chemical Name :(2S,3aS,7aS)-1-(tert-Butoxycarbonyl)octahydro-1H-indole-2-carboxylic acid

Calculated chemistry of [ 109523-13-9 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 19
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.86
Num. rotatable bonds : 4
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 75.48
TPSA : 66.84 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.11 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.6
Log Po/w (XLOGP3) : 2.58
Log Po/w (WLOGP) : 2.26
Log Po/w (MLOGP) : 1.85
Log Po/w (SILICOS-IT) : 0.89
Consensus Log Po/w : 2.03

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.87
Solubility : 0.362 mg/ml ; 0.00134 mol/l
Class : Soluble
Log S (Ali) : -3.63
Solubility : 0.0628 mg/ml ; 0.000233 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.02
Solubility : 25.9 mg/ml ; 0.0962 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 3.5

Safety of [ 109523-13-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 109523-13-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 109523-13-9 ]

[ 109523-13-9 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 112253-70-0 ]
  • [ 109523-13-9 ]
  • [ 1446082-36-5 ]
YieldReaction ConditionsOperation in experiment
50.6 g With pyridine; oxalyl dichloride; In dichloromethane; at 0 - 20℃; for 2h;Inert atmosphere; C1COCOC1 ( 44.4 mL, 510.2 mmol) was added dropwise to the mixture of PR-13 (100.6 g, 374 mmol), <strong>[112253-70-0]2-amino-4-bromobenzamide</strong> (73.2 g, 340 mmol) and pyridine (760 mL) under nitrogen at 0C. The mixture was stirred for 2 hour at room temperature. The solvent was removed in vacuo. Saturated NaHC03 was added to the residue and the resulting mixture was extracted by ethyl acetate for three times. The combined organic layers were washed with saturated NaHC03, brine and dried over Na2S04. The solvent was removed in vacuo. The obtained residue was purified by chromatography (CH2Cl2:MeOH=50: l) resulting in an intermediate amide compound (50.6 g). Method A2; Rt: 1.15 min. m/z=:490.1 (M+Na)+ Exact mass: 467.1 A solution of the above obtained intermediate (50.61g), Na2C03 (34.5 lg. 325.6 mmol), H20 (300 mL) and CH3CH2OH (300 mL) was stirred for 3 hours at reflux. EtOH was removed in vacuo and the mixture was extracted with ethyl acetate (3 x 300 mL). The combined organic layers were dried over Na2S04 and concentrated in vacuo. The obtained residue was washed with t-butyl methyl ether resulting in compound QA-9 (39.2 g). Method A2; Rt: 1.37 min. m/z=:448.1 (M+H)+ Exact mass: 447.1
50.6 g With pyridine; oxalyl dichloride; at 0 - 20℃; for 2h;Inert atmosphere; C1COCOC1 ( 44.4 mL, 510.2 mmol) was added dropwise to the mixture of PR-13 (100.6 g, 374 mmol), <strong>[112253-70-0]2-amino-4-bromobenzamide</strong> (73.2 g, 340 mmol) and pyridine (760 mL) under nitrogen at 0C. The mixture was stirred for 2 hour at room temperature. The solvent was removed in vacuo. Saturated NaHC03 was added to the residue and the resulting mixture was extracted by ethyl acetate for three times. The combined organic layers were washed with saturated NaHC03, brine and dried over Na2S04. The solvent was removed in vacuo. The obtained residue was purified by chromatography (CH2Cl2:MeOH=50: l) resulting in an intermediate amide compound (50.6 g). Method A2; Rt: 1.15 min. m/z=:490.1 (M+Na)+ Exact mass: 467.1 A solution of the above obtained intermediate (50.61g), Na2C03 (34.5 lg. 325.6 mmol), H20 (300 mL) and CH3CH2OH (300 mL) was stirred for 3 hours at reflux. EtOH was removed in vacuo and the mixture was extracted with ethyl acetate (3 x 300 mL). The combined organic layers were dried over Na2S04 and concentrated in vacuo. The obtained residue was washed with t-butyl methyl ether resulting in compound QA-9 (39.2 g). Method A2; Rt: 1.37 min. m/z=:448.1 (M+H)+ Exact mass: 447.1
Recommend Products
Same Skeleton Products

Technical Information

Historical Records
; ;